A Prospective Randomized Crossover Trial of Systemic Chemotherapy in Patients with Low-Grade Mucinous Appendiceal Adenocarcinoma

Authors

Abdelrahman M. Yousef, The University of Texas MD Anderson Cancer Center
John Paul Shen, The University of Texas MD Anderson Cancer Center
Fadl Zeineddine, The University of Texas MD Anderson Cancer Center
Mohammad Zeineddine, The University of Texas MD Anderson Cancer Center
Becky Slack Tidwell, The University of Texas MD Anderson Cancer Center
Robert A. Wolff, The University of Texas MD Anderson Cancer Center
Aurelio Matamoros, The University of Texas MD Anderson Cancer Center
Wai Chin Foo, The University of Texas MD Anderson Cancer Center
Melissa Taggart, The University of Texas MD Anderson Cancer Center
Abhineet Uppal, The University of Texas MD Anderson Cancer Center
Christopher Scally, The University of Texas MD Anderson Cancer Center
Paul Mansfield, The University of Texas MD Anderson Cancer Center
Safia Rafeeq, The University of Texas MD Anderson Cancer Center
Kanwal Raghav, The University of Texas MD Anderson Cancer Center
Michael J. Overman, The University of Texas MD Anderson Cancer Center
Keith Fournier, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00097

Publication Date

2022

Department

Gastrointestinal Medical Oncology

Research Category

Clinical Data Science

Recommended Citation

Yousef, Abdelrahman M.; Shen, John Paul; Zeineddine, Fadl; Zeineddine, Mohammad; Tidwell, Becky Slack; Wolff, Robert A.; Matamoros, Aurelio; Foo, Wai Chin; Taggart, Melissa; Uppal, Abhineet; Scally, Christopher; Mansfield, Paul; Rafeeq, Safia; Raghav, Kanwal; Overman, Michael J.; and Fournier, Keith, "A Prospective Randomized Crossover Trial of Systemic Chemotherapy in Patients with Low-Grade Mucinous Appendiceal Adenocarcinoma" (2022). Leading Edge of Cancer Research Symposium. 49.
doi:https://doi.org/10.52519/00097